Sequential is the world’s leading microbiome platform for skin, scalp and intimate area clinical testing. Unlike others reling on in-vitro studies, Sequential conducts invivo testing, ensuring high-quality scientific data supports formulations. The company upholds rigorous study designs, drawing from academic standards to bring credibility to an otherwise unregulated industry. With over 30,000 microbiome samples collected, Sequential integrates microbiome, clinical, and formulation data using machine learning for advanced personal care and healthcare applications. Their groundbreaking Targeted Skin Panel is the industry’s first microbiome-malodor, and sun/ UV exposure through the lens of the microbiome. Sequential’s clinically validated adhesive patch enables efficient, remote microbial sampling in just 10 secondsoutperforming traditional swabbing techniques.

CONTACT

Sequential

https://www.sequentialskin.com/